Skip to main content
. 2017 Feb 27;8(13):21930–21937. doi: 10.18632/oncotarget.15748

Figure 1. CONSORT diagram.

Figure 1

VHIO, Vall d’Hebron Institute of Oncology; GEICAM, Spanish Breast Cancer Research Group; CBM Rome, Università Campus Bio-Medico di Roma.